HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine

Anterior gradient 2–derived peptide upregulates major histocompatibility complex class I–related chains A/B in hepatocellular carcinoma cells

(2020) Jing Bian et al.   LIFE SCIENCES

Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment

(2020) Karlyn E Pollack et al.   Journal for ImmunoTherapy of Cancer

NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors

(2019) Robin Parihar et al.   Cancer Immunology Research

Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways

(2018) Jushuang Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Oxymatrine Inhibits Influenza A Virus Replication and Inflammation via TLR4, p38 MAPK and NF-κB Pathways

(2018) Jian-Ping Dai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

(2018) Vanessa M. Tubb et al.   Journal for ImmunoTherapy of Cancer

Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis

(2018) Qiuwan Wu et al.   CANCER LETTERS

Identification of non-mutated neoantigens presented by TAP-deficient tumors

(2018) Koen A. Marijt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

(2018) Tatjana Bilich et al.   BLOOD

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

(2018) Pascale André et al.   CELL

Engineering Natural Killer Cells for Cancer Immunotherapy

(2017) Katayoun Rezvani et al.   MOLECULAR THERAPY

Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer

(2017) Jiaying Shen et al.   Cell Death & Disease

Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides

(2017) Alessandro Zorzi et al.   Nature Communications

IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours

(2017) Hyungseok Seo et al.   Nature Communications

Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines

(2017) Eleni Maria Varypataki et al.   Cancer Immunology Research

MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer

(2016) Riki Okita et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma

(2016) Wataru Obara et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Rejection versus escape: the tumor MHC dilemma

(2016) Federico Garrido et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Emerging Opportunities and Challenges in Cancer Immunotherapy

(2016) T. L. Whiteside et al.   CLINICAL CANCER RESEARCH

Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules

(2016) Wenbin Ma et al.   JOURNAL OF IMMUNOLOGY

TLR7/8 agonists promote NK–DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma

(2015) Zhixia Zhou et al.   CANCER LETTERS

Peptide therapeutics: current status and future directions

(2015) Keld Fosgerau et al.   DRUG DISCOVERY TODAY

In situ Delivery of Tumor Antigen– and Adjuvant-Loaded Liposomes Boosts Antigen-Specific T-Cell Responses by Human Dermal Dendritic Cells

(2015) Martine A. Boks et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

(2015) B. M. Carreno et al.   SCIENCE

Dendritic cell specific targeting of MyD88 signalling pathways in vivo

(2014) Catharina Arnold-Schrauf et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The immune epitope database (IEDB) 3.0

(2014) Randi Vita et al.   NUCLEIC ACIDS RESEARCH

Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer

(2014) Qiuwan Wu et al.   World Journal of Surgical Oncology

Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation

(2013) Jessica M. Moffat et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer

(2013) Hajime Ishikawa et al.   Gastric Cancer

Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity

(2012) Shuli Zhao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

(2011) M J M Gooden et al.   BRITISH JOURNAL OF CANCER

Toll-like receptors and innate immunity

(2009) Himanshu Kumar et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches

(2009) Terry J. Fry et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation

(2008) Martijn S. Bijker et al.   EUROPEAN JOURNAL OF IMMUNOLOGY